
newsJan 19, 202127:46pending
Controlling Advanced Technology Exports: A Conversation with Roslyn Layton and James Lewis
About this episode
In this episode, Dr. Roslyn Layton and Dr. James Lewis discuss how to control the proliferation of technologies for military use with a special focus on China. Our guests explain the history of US export policy regarding advanced technology, noting the delicate balance between opportunities for private enterprise and the needs of national security. They describe the Wassenar Agreement and its impact on current US advanced technology exports to China. Dr. Layton argues in favor of US designation of companies as military-end-users in China as one method to prevent US technology from being transferred to China’s military. Dr. Lewis analyzes China’s progress in its semiconductor industry, noting that China is still dependent on Western technology. Our guests also interpret China’s actions in retaliation to international technology export restrictions. Lastly, our guests evaluate how the Trump administration has acted in its approach to China and recommend actions the incoming Biden administration should take.
Dr. Roslyn Layton is a visiting researcher at Aalborg University Center for Communication, Media, and Information Technologies and Senior Vice President at Strand Consult. Dr. Layton focuses on evidence-based policy for the information, communications, and digital technology industries. Dr. James Lewis is a senior vice president and director of the Strategic Technologies Program at CSIS. He has authored numerous publications on the relationship between technology, innovation, and national power.
Get every episode summarized
Each time ChinaPower publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from ChinaPower

Part II: Biotechnology in U.S.-China Competition: A Conversation with Caitlin Fr...
ChinaPower
Aug 27, 202649:28pending

Part I: Biotechnology in U.S.-China Competition: A Conversation with Senator Tod...
ChinaPower
Aug 13, 202626:55pending

China's Moonshot AI’s Kimi K3 and Open AI Strategy: A Conversation with Ngor Luo...
ChinaPower
Jul 30, 202639:54pending

Escalating Japan-China Tensions: A Conversation with Kristi Govella
ChinaPower
Jul 17, 202634:43pending